VCEL VCEL

Vericel Stock Price

28.07
1.33 (4.97%)
Upgrade to Real-Time
Afterhours (Closed)
28.07
Volume 460,534
Bid Price 16.50
Ask Price 31.24
News -
Day High 28.10

Low
25.11

52 Week Range

High
68.94

Day Low 26.63
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Vericel Corporation VCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.33 4.97% 28.07 17:32:56
Open Price Low Price High Price Close Price Prev Close
26.94 26.63 28.10 28.07 26.74
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,349 460,534 $ 27.46 $ 12,644,710 - 25.11 - 68.94
Last Trade Time Type Quantity Stock Price Currency
16:43:54 47 $ 28.07 USD

Period:

Draw Mode:

Vericel Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.32B 47.12M 33.94M $ 156.18M $ -11.28M -0.16 -112.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 598.25k 4.00%

more financials information »

Vericel News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VCEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.3728.4526.0427.00332,595-0.30-1.06%
1 Month31.1632.1625.1127.71518,281-3.09-9.92%
3 Months40.3541.5425.1133.26519,686-12.28-30.43%
6 Months39.1843.969925.1135.13522,567-11.11-28.36%
1 Year54.9368.9425.1142.34447,240-26.86-48.9%
3 Years15.7568.946.7829.92559,52912.3278.22%
5 Years2.9568.942.5520.88660,96625.12851.53%

Vericel Description

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.


Your Recent History
NASDAQ
VCEL
Vericel
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.